CDC vaccine panel postpones decision on newborn hepatitis B vaccine

Published September 19, 2025 9:58am ET



The Centers for Disease Control and Prevention’s vaccine safety panel on Friday morning agreed to postpone a decision to no longer recommend the newborn dose of the hepatitis B vaccine.

The vote from all but one of the 12 members of the Advisory Committee on Immunization Practices comes as a de-escalation in the mounting tensions over vaccine policy under the leadership of Health and Human Services Secretary Robert F. Kennedy Jr., a longtime skeptic of the status quo on childhood vaccines. 

Already a print subscriber? Click here to login/register your account

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.